SG71923A1 - Use of nanodispersions in pharmaceutical end formulations - Google Patents

Use of nanodispersions in pharmaceutical end formulations

Info

Publication number
SG71923A1
SG71923A1 SG1999002127A SG1999002127A SG71923A1 SG 71923 A1 SG71923 A1 SG 71923A1 SG 1999002127 A SG1999002127 A SG 1999002127A SG 1999002127 A SG1999002127 A SG 1999002127A SG 71923 A1 SG71923 A1 SG 71923A1
Authority
SG
Singapore
Prior art keywords
nanodispersions
pharmaceutical end
end formulations
formulations
pharmaceutical
Prior art date
Application number
SG1999002127A
Other languages
English (en)
Inventor
Andreas Werner Supersaxo
Hans Georg Weder
Dietmar Huglin
Joachim Friedrich Roding
Original Assignee
Ciba Sc Holding Ag
Vesifact Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Sc Holding Ag, Vesifact Ag filed Critical Ciba Sc Holding Ag
Publication of SG71923A1 publication Critical patent/SG71923A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1999002127A 1998-05-11 1999-05-05 Use of nanodispersions in pharmaceutical end formulations SG71923A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP98810422 1998-05-11

Publications (1)

Publication Number Publication Date
SG71923A1 true SG71923A1 (en) 2000-04-18

Family

ID=8236078

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1999002127A SG71923A1 (en) 1998-05-11 1999-05-05 Use of nanodispersions in pharmaceutical end formulations

Country Status (20)

Country Link
US (2) US7081253B2 (ko)
EP (1) EP0956853B1 (ko)
JP (1) JP4755742B2 (ko)
KR (1) KR100622285B1 (ko)
CN (1) CN1220483C (ko)
AR (1) AR019274A1 (ko)
AT (1) ATE312597T1 (ko)
AU (1) AU767896B2 (ko)
BR (1) BRPI9902068B8 (ko)
CZ (1) CZ166999A3 (ko)
DE (1) DE59912910D1 (ko)
ES (1) ES2253871T3 (ko)
HU (1) HUP9901570A2 (ko)
ID (1) ID22565A (ko)
MY (1) MY133019A (ko)
PL (1) PL332934A1 (ko)
RU (1) RU2224505C2 (ko)
SG (1) SG71923A1 (ko)
TW (1) TWI241915B (ko)
ZA (1) ZA993200B (ko)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9908309D0 (en) * 1999-04-12 1999-06-02 Phares Pharm Res Nv Lipid aggregate forming compositions and their use
FR2805761B1 (fr) * 2000-03-02 2002-08-30 Mainelab Nanocapsules lipidiques, procede de preparation et utilisation comme medicament
TW586945B (en) * 2001-01-12 2004-05-11 Novartis Ag Lens care product containing dexpanthenol
US20030113366A1 (en) * 2001-12-14 2003-06-19 Macgregor Alexander Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents
AT6609U3 (de) * 2003-04-07 2004-04-26 Unipack Ges M B H Abfuell Und Verfahren zum herstellen einer klaren lecithin enthaltenden oralen zubereitung
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
TWI350183B (en) * 2003-12-31 2011-10-11 Ind Tech Res Inst A liposome and a preparation method
EP1768650B1 (en) * 2004-06-04 2008-07-16 Camurus Ab Liquid depot formulations
US20060198891A1 (en) * 2004-11-29 2006-09-07 Francois Ravenelle Solid formulations of liquid biologically active agents
US20090107495A1 (en) * 2005-07-21 2009-04-30 National Institute For Materials Science Device for inhalation of medicine
US7745400B2 (en) 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
CA2680606C (en) 2006-03-29 2014-08-05 Wayne State University Liposomal nanoparticles and other formulations of fenretinide for use in therapy and drug delivery
JP4840031B2 (ja) 2006-08-31 2011-12-21 ソニー株式会社 ナビゲーション装置、ナビゲーション処理方法及びナビゲーション処理プログラム
EP1938801A1 (en) * 2006-12-22 2008-07-02 Biofrontera Bioscience GmbH Nanoemulsion
CL2008000037A1 (es) * 2007-01-16 2008-10-10 Bayer Consumer Care Ag Solucion coloidal que comprende al menos un ingrediente activo, al menos una molecula formadora de membrana y al menos un componente espumante; procedimiento para fabricar la solucion coloidal; y su uso para tratar trastornos dermatologicos.
US8309129B2 (en) 2007-05-03 2012-11-13 Bend Research, Inc. Nanoparticles comprising a drug, ethylcellulose, and a bile salt
WO2008135855A2 (en) 2007-05-03 2008-11-13 Pfizer Products Inc. Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer
WO2008149230A2 (en) 2007-06-04 2008-12-11 Pfizer Products Inc. Nanoparticles comprising drug, a non-ionizable cellulosic polymer and tocopheryl polyethylene glycol succinate
US8974827B2 (en) 2007-06-04 2015-03-10 Bend Research, Inc. Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
WO2009073215A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Pharmaceutical compositions comprising nanoparticles and a resuspending material
WO2009073216A1 (en) 2007-12-06 2009-06-11 Bend Research, Inc. Nanoparticles comprising a non-ionizable polymer and an amine-functionalized methacrylate copolymer
CN100536826C (zh) * 2007-12-28 2009-09-09 清华大学 一种绵羊油纳米乳液及其制备方法和应用
US20110033545A1 (en) * 2009-08-06 2011-02-10 Absize, Inc. Topical pharmaceutical preparations having both a nanoparticle solution and a nanoparticle suspension and methods for the treatment of acute and chronic pain therewith
FR2949063B1 (fr) * 2009-08-11 2011-09-30 Pf Medicament Composition pharmaceutique comprenant un ester de dha destinee a etre administree par voie parenterale
DE202010004750U1 (de) 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut
CN102277748A (zh) * 2010-06-12 2011-12-14 罗莱家纺股份有限公司 纳米维生素微胶囊整理剂的使用方法
KR101494594B1 (ko) * 2011-08-30 2015-02-23 주식회사 종근당 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586790B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 음이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586789B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 양이온성 약리학적 활성물질의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
KR101586791B1 (ko) 2012-12-28 2016-01-19 주식회사 종근당 ＧｎＲＨ 유도체의 서방성 지질 초기제제 및 이를 포함하는 약제학적 조성물
EP3583954A1 (en) * 2018-06-19 2019-12-25 neubourg skin care GmbH Nanodispersions of birch bark extract, electrospun fibers containing such nanodispersions and their use for the treatment of wounds
CN111388744B (zh) * 2020-01-15 2021-05-18 华中科技大学 一种凝胶贮库及其制法与制备术后止血制剂的应用
EP4173614A1 (en) 2020-06-30 2023-05-03 Chong Kun Dang Pharmaceutical Corp. Injectable composition comprising gnrh derivatives

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3150990A1 (de) 1981-12-23 1983-06-30 A. Nattermann & Cie GmbH, 5000 Köln Neue pflanzenschutzmittelsuspensionskonzentrate
US4675193A (en) * 1983-10-31 1987-06-23 Borden, Inc. Cheese-flavored substance and method of producing same
US4816247A (en) * 1985-09-11 1989-03-28 American Cyanamid Company Emulsion compositions for administration of sparingly water soluble ionizable hydrophobic drugs
CA1332940C (en) 1986-08-07 1994-11-08 Henrich Hasko Paradies N-alkylated quaternary nitrogen-containing heterocycles
ES2068197T3 (es) 1987-01-27 1995-04-16 Vestar Inc Vehiculo de liberacion a base de fosfolipidos para ingredientes activos insolubles en agua.
EP0349150B1 (en) 1988-06-20 1994-08-17 Shiseido Company Limited Transparent compostition
ES2052016T3 (es) * 1988-09-29 1994-07-01 Shiseido Co Ltd Composicion emulsionada.
FR2648462B1 (fr) 1989-06-15 1994-01-28 Oreal Procede pour ameliorer l'efficacite therapeutique de corticosteroides liposolubles et composition pour la mise en oeuvre de ce procede
JP2785981B2 (ja) * 1989-11-20 1998-08-13 株式会社資生堂 乳化組成物
JPH06507172A (ja) * 1991-04-19 1994-08-11 アフィニティー　バイオテック，インコーポレイテッド 転換可能なミクロエマルジョン処方剤
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
ZA925581B (en) * 1991-07-26 1993-05-14 Smithkline Beecham Corp Pharmaceutical microemulsions.
US5260065A (en) 1991-09-17 1993-11-09 Micro Vesicular Systems, Inc. Blended lipid vesicles
IL101007A (en) * 1992-02-18 1997-08-14 Pharmos Ltd Dry stable compositions prepared by lyophilization
IL101387A (en) 1992-03-26 1999-11-30 Pharmos Ltd Emulsion with enhanced topical and/or transdermal systemic effect utilizing submicron oil droplets
US5576016A (en) * 1993-05-18 1996-11-19 Pharmos Corporation Solid fat nanoemulsions as drug delivery vehicles
CH685674A5 (de) 1993-12-19 1995-09-15 Marigen Sa Ultramikroemulsionen aus spontan dispergierbaren Konzentraten mit pharmakologisch wirksamen Estern von Apocarotinolen.
IL129547A (en) * 1994-10-26 2001-01-11 Novartis Ag Pharmaceutical compositions comprising a macrolide and an acid
EP0711556A1 (de) * 1994-11-09 1996-05-15 Ciba-Geigy Ag Intravenöse Lösungen für ein Staurosporinderivat
EP0733358A3 (de) * 1995-03-21 1998-05-20 Novartis AG Intravenös applizierbare Nanosuspensionen
WO1996037192A1 (en) * 1995-05-26 1996-11-28 Vesifact Ag Pharmaceutical and cosmetic compositions containing sphingo- and glycolipids
DE19522693A1 (de) 1995-06-22 1997-01-02 Dianorm G Maierhofer Gmbh Zusammensetzung zur Herstellung feindisperser Systeme und Verfahren zu ihrer Herstellung
JP3508314B2 (ja) * 1995-08-18 2004-03-22 大正製薬株式会社 ビタミンｃを配合した液剤
EP0866689A1 (de) * 1995-12-12 1998-09-30 Vesifact Ag Cortisolspray zur topischen verabreichung
US6245349B1 (en) * 1996-02-23 2001-06-12 éLAN CORPORATION PLC Drug delivery compositions suitable for intravenous injection
ATE240088T1 (de) * 1996-12-13 2003-05-15 Vesifact Ag Kosmetische präparate in form einer nanodispersion
US6028067A (en) * 1997-12-05 2000-02-22 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition

Also Published As

Publication number Publication date
BRPI9902068B8 (pt) 2021-05-25
DE59912910D1 (de) 2006-01-19
TWI241915B (en) 2005-10-21
AR019274A1 (es) 2002-02-13
HU9901570D0 (en) 1999-07-28
EP0956853A3 (de) 2000-01-05
ES2253871T3 (es) 2006-06-01
US20030190347A1 (en) 2003-10-09
RU2224505C2 (ru) 2004-02-27
CZ166999A3 (cs) 1999-11-17
KR19990088156A (ko) 1999-12-27
PL332934A1 (en) 1999-11-22
BR9902068A (pt) 2000-06-06
EP0956853B1 (de) 2005-12-14
BR9902068B1 (pt) 2014-10-29
JPH11335266A (ja) 1999-12-07
AU767896B2 (en) 2003-11-27
ID22565A (id) 1999-11-11
ATE312597T1 (de) 2005-12-15
US7871642B2 (en) 2011-01-18
ZA993200B (en) 1999-11-11
MY133019A (en) 2007-10-31
AU2805099A (en) 1999-11-18
HUP9901570A2 (hu) 2001-06-28
US7081253B2 (en) 2006-07-25
JP4755742B2 (ja) 2011-08-24
EP0956853A2 (de) 1999-11-17
US20060292191A1 (en) 2006-12-28
KR100622285B1 (ko) 2006-09-11
CN1235017A (zh) 1999-11-17
CN1220483C (zh) 2005-09-28

Similar Documents

Publication Publication Date Title
SG71923A1 (en) Use of nanodispersions in pharmaceutical end formulations
SG72949A1 (en) Use of nanodispersions in cosmetic end formulations
SG79255A1 (en) Pharmaceutical formulations
HK1061037A1 (en) Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same
IL131201A0 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
HUP0200548A2 (hu) Gyógyszerészeti készítmények és alkalmazásuk
GB9713149D0 (en) Pharmaceutical formulations
GB0101035D0 (en) Formulation and use thereof
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use
GB9818927D0 (en) Pharmaceutical formulation
ZA982952B (en) Pseudo-peptide compounds their preparation and use in pharmaceutical formulations
EP1275657A4 (en) PEPTIDE DERIVATIVES AND MEDICINAL COMPOSITIONS
AU2001262928A1 (en) Pharmaceutical compositions and their use
IL134240A0 (en) Inositol derivatives and their pharmaceutical use
GB9817470D0 (en) Pharmaceutical formulation
GB0021927D0 (en) Use of pharmaceutical combination
HUP0001584A3 (en) Pharmaceutical formulations comprising amoxocyllin and clavulanate
GB9827835D0 (en) Pharmaceutical compositions and their use
GB9821537D0 (en) Pharmaceutical compositions and their use
GB0014420D0 (en) Pharmaceutical compositions and their use
GB9805931D0 (en) Pharmaceutical formulations
GB9820837D0 (en) Pharmaceutical formulations
GB9828205D0 (en) Pharmaceutical formulations
GB9807556D0 (en) Pharmaceutical formulations
GB9816558D0 (en) Pharmaceutical formulations